Literature DB >> 11134894

4-dimethylamino-3',4'-dimethoxychalcone downregulates iNOS expression and exerts anti-inflammatory effects.

F Herencia1, M L Ferrándiz, A Ubeda, I Guillén, J N Dominguez, J E Charris, G M Lobo, M J Alcaraz.   

Abstract

Reactive oxygen and nitrogen species contribute to the pathophysiology of inflammatory conditions. We have studied the effects of a novel superoxide scavenger, 4-dimethylamino-3', 4'-dimethoxychalcone (CH11) in macrophages and in vivo. CH11 has been shown to inhibit the chemiluminescence induced by zymosan in mouse peritoneal macrophages and the cytotoxic effects of superoxide. In the same cells, the modulation by superoxide of nitric oxide (NO) production in response to zymosan was investigated. CH11 was more effective than the membrane-permeable scavenger Tiron for inhibition of inducible nitric oxide synthase (iNOS) protein expression and nitrite production. We have shown that CH11 inhibited chemiluminescence in vivo, as well as cell migration, and eicosanoid and tumor necrosis factor-alpha (TNF-alpha) levels in the mouse air pouch injected with zymosan. This chalcone derivative also exerted anti-inflammatory effects in the carrageenan paw oedema.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11134894     DOI: 10.1016/s0891-5849(00)00443-3

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  8 in total

1.  Modulation of haem oxygenase-1 expression by nitric oxide and leukotrienes in zymosan-activated macrophages.

Authors:  A M Vicente; M I Guillén; M J Alcaraz
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

2.  Novel chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells.

Authors:  Vineet Kumar; Sarvesh Kumar; Mohammad Hassan; Hailong Wu; Rajesh K Thimmulappa; Amit Kumar; Sunil K Sharma; Virinder S Parmar; Shyam Biswal; Sanjay V Malhotra
Journal:  J Med Chem       Date:  2011-05-19       Impact factor: 7.446

3.  Role of nuclear factor-kappaB and heme oxygenase-1 in the mechanism of action of an anti-inflammatory chalcone derivative in RAW 264.7 cells.

Authors:  María José Alcaraz; Ana María Vicente; Amparo Araico; José N Dominguez; María Carmen Terencio; María Luisa Ferrándiz
Journal:  Br J Pharmacol       Date:  2004-07-12       Impact factor: 8.739

4.  Therapeutic administration of 3,4,5-trimethoxy-4'-fluorochalcone, a selective inhibitor of iNOS expression, attenuates the development of adjuvant-induced arthritis in rats.

Authors:  Javier Rojas; Miguel Payá; Isabel Devesa; José N Dominguez; M Luisa Ferrándiz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-08-02       Impact factor: 3.000

5.  Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.

Authors:  Sabrina F Lisboa; Felipe V Gomes; Andréia L Silva; Daniela L Uliana; Laura H A Camargo; Francisco S Guimarães; Fernando Q Cunha; Sâmia R L Joca; Leonardo B M Resstel
Journal:  Int J Neuropsychopharmacol       Date:  2015-01-24       Impact factor: 5.176

Review 6.  Effects of chalcone derivatives on players of the immune system.

Authors:  Jian Sian Lee; Syed Nasir Abbas Bukhari; Norsyahida Mohd Fauzi
Journal:  Drug Des Devel Ther       Date:  2015-08-19       Impact factor: 4.162

Review 7.  Immunosuppressive Effects of Natural α,β-Unsaturated Carbonyl-Based Compounds, and Their Analogs and Derivatives, on Immune Cells: A Review.

Authors:  Laiba Arshad; Ibrahim Jantan; Syed Nasir Abbas Bukhari; Md Areeful Haque
Journal:  Front Pharmacol       Date:  2017-01-30       Impact factor: 5.810

8.  The Plant-Derived Chalcone 2,2',5'-Trihydroxychalcone Provides Neuroprotection against Toll-Like Receptor 4 Triggered Inflammation in Microglia.

Authors:  Manasi Jiwrajka; Alexandra Phillips; Matt Butler; Miriam Rossi; Jennifer M Pocock
Journal:  Oxid Med Cell Longev       Date:  2015-12-21       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.